SYBX SYNLOGIC INC Investments/Divestments 8-K Filing 2023 - Extension of Option Agreement Synlogic, Inc. extends the deadline for Roche to exercise an exclusive option right for the development of a Synthetic Biotic medicine for inflammatory bowel disease.Get access to all SEC 8-K filings of the SYNLOGIC INC